The Lunula Laser is a revolutionary cold low-level laser therapy bringing new hope to people suffering from toenail fungus (onychomycosis). The Lunula Laser poses none of the risks or harmful side effects associated with oral anti-fungal medications or hot laser treatments. The Lunula Laser is Safe, effective and painless. Until the arrival of the Lunula Laser, sufferers of toenail fungus (onchomycosis) had very few options for successfully treating onychomycosis safely and effectively.
It’s always good to be at the forefront of something special.
Back in 2009 The London Nail Laser Clinic became the European pioneer of the PinPointe FootLaser – a dramatic breakthrough in the treatment of onychomycosis (nail fungus).
Three years on, it’s been confirmed this month that already more than 100,000 procedures have been performed worldwide using PinPointe. That’s a remarkable statistic, and even more so when you consider that it outstrips many of the other treatment options put together. But then again, maybe we shouldn’t be so surprised.
The PinPointe FootLaser was, after all, the first light-based device to be formally approved by the medical regulators the USA, where it was developed by NuvoLase. And, even as we approach 2013, it remains one of an elite few devices on the market today with documented, clinically proven efficacy.
Small wonder that Steven Duddy, boss of NuvoLase in California, describes the global progression beyond 100,000 treatments as an “exciting and important milestone”.
Requiring no anaesthetic, the PinPointe FootLaser uses a laser infra red light to pass through into the nail and nail bed. This light is absorbed by the fungal cells, specifically causing them to vaporise. Not only is it an effective alternative to potentially risky oral medications, there are no side effects. Nor is there any recovery period or effect on activity after treatment.
As one leading foot surgeon in America put it: “This breakthrough technology has changed the way we approach patients suffering from unsightly nail fungus and has changed the lives of many.”
The London Nail Laser Clinic continues to embrace and enhance the technology, with impressive results. Nearly all patients receiving treatment show some degree of improvement at six months – and more than three quarters of these show significant healthy nail growth.
London Nail Laser Clinic Founders Martine Abrahams BSc(Hons) MChS and Michael Abrahams BSc(Hons) MChS have combined over 24 years experience in podiatry and are well known in the industry for their extensive knowledge of nail fungus.
In the last several months they have been incredibly busy speaking publicly at international conferences for various Societies of Chiropodists and Podiatrists.
At the Society of Chiropodists and Podiatrists’ Annual Conference in Glasgow, 11-13 October 2012 Martine specifically spoke about the launch of a new laser to the market; a laser which is one of a kind as it is known to be the only “painless” treatment available. Over a six month period two simple 12 minute sessions with regular follow up show significant improvements. In the majority of cases who have had the “painless” treatment, 97% of patients had positive results after the 6 month period.
“These results suggest that this new laser treatment is more effective than other laser treatments available in the UK, with the advantage of it being pain free”, says Martine. ‘It also has no side effects, unlike many of the antifungal medications such as creams and medication used today. We would certainly recommend it as an alternative or additional approach to the treatment of this common condition.”
The next conference Martine will be attending is the Society of Chiropodists and Podiatrists of Ireland. She will be discussing the extensive and informative experience the London Nail Laser Clinic has had of treating nail fungus by laser throughout the years. She will be demonstrating how important it is to suggest the correct treatment to avoid serious health risks and suggest ways of how to eliminate peoples fear of nail fungus treatment.
The Conference will take place at the convention centre in Ireland on 10th November 2012.